235 related articles for article (PubMed ID: 28471483)
1. Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence-Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein-Interferon-β Feedback Loop.
Gao L; Bird AK; Meednu N; Dauenhauer K; Liesveld J; Anolik J; Looney RJ
Arthritis Rheumatol; 2017 Aug; 69(8):1623-1635. PubMed ID: 28471483
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow mesenchymal stem cells from patients with SLE maintain an interferon signature during in vitro culture.
Gao L; OConnell M; Allen M; Liesveld J; McDavid A; Anolik JH; Looney RJ
Cytokine; 2020 Aug; 132():154725. PubMed ID: 31153744
[TBL] [Abstract][Full Text] [Related]
3. IFN
Gao L; Liesveld J; Anolik J; Mcdavid A; Looney RJ
Lupus; 2020 Aug; 29(9):1040-1049. PubMed ID: 32515653
[TBL] [Abstract][Full Text] [Related]
4. p53/p21 Pathway involved in mediating cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients.
Gu Z; Jiang J; Tan W; Xia Y; Cao H; Meng Y; Da Z; Liu H; Cheng C
Clin Dev Immunol; 2013; 2013():134243. PubMed ID: 24151513
[TBL] [Abstract][Full Text] [Related]
5. Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway.
Gu Z; Tan W; Feng G; Meng Y; Shen B; Liu H; Cheng C
Mol Cell Biochem; 2014 Feb; 387(1-2):27-37. PubMed ID: 24130040
[TBL] [Abstract][Full Text] [Related]
6. JAK-STAT signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients.
Ji J; Wu Y; Meng Y; Zhang L; Feng G; Xia Y; Xue W; Zhao S; Gu Z; Shao X
Acta Biochim Biophys Sin (Shanghai); 2017 Mar; 49(3):208-215. PubMed ID: 28177455
[TBL] [Abstract][Full Text] [Related]
7. Prion-like Aggregation of Mitochondrial Antiviral Signaling Protein in Lupus Patients Is Associated With Increased Levels of Type I Interferon.
Shao WH; Shu DH; Zhen Y; Hilliard B; Priest SO; Cesaroni M; Ting JP; Cohen PL
Arthritis Rheumatol; 2016 Nov; 68(11):2697-2707. PubMed ID: 27110677
[TBL] [Abstract][Full Text] [Related]
8. Leptin and Neutrophil-Activating Peptide 2 Promote Mesenchymal Stem Cell Senescence Through Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway in Patients With Systemic Lupus Erythematosus.
Chen H; Shi B; Feng X; Kong W; Chen W; Geng L; Chen J; Liu R; Li X; Chen W; Gao X; Sun L
Arthritis Rheumatol; 2015 Sep; 67(9):2383-93. PubMed ID: 25989537
[TBL] [Abstract][Full Text] [Related]
9. Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells.
Ji J; Fu T; Dong C; Zhu W; Yang J; Kong X; Zhang Z; Bao Y; Zhao R; Ge X; Sha X; Lu Z; Li J; Gu Z
Aging (Albany NY); 2019 Jul; 11(13):4338-4353. PubMed ID: 31303606
[TBL] [Abstract][Full Text] [Related]
10. Restored immunosuppressive effect of mesenchymal stem cells on B cells after olfactory 1/early B cell factor-associated zinc-finger protein down-regulation in patients with systemic lupus erythematosus.
Feng X; Che N; Liu Y; Chen H; Wang D; Li X; Chen W; Ma X; Hua B; Gao X; Tsao BP; Sun L
Arthritis Rheumatol; 2014 Dec; 66(12):3413-23. PubMed ID: 25219468
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of p16INK4A promotes cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients.
Gu Z; Cao X; Jiang J; Li L; Da Z; Liu H; Cheng C
Cell Signal; 2012 Dec; 24(12):2307-14. PubMed ID: 22820504
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
[TBL] [Abstract][Full Text] [Related]
13. PTEN/Akt-p27(kip1) Signaling Promote the BM-MSCs Senescence and Apoptosis in SLE Patients.
Tan W; Gu Z; Shen B; Jiang J; Meng Y; Da Z; Liu H; Tao T; Cheng C
J Cell Biochem; 2015 Aug; 116(8):1583-94. PubMed ID: 25649549
[TBL] [Abstract][Full Text] [Related]
14. Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus.
Geng L; Tang X; Wang S; Sun Y; Wang D; Tsao BP; Feng X; Sun L
Front Immunol; 2020; 11():233. PubMed ID: 32133007
[TBL] [Abstract][Full Text] [Related]
15. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.
Cipriani P; Di Benedetto P; Liakouli V; Del Papa B; Di Padova M; Di Ianni M; Marrelli A; Alesse E; Giacomelli R
Clin Exp Immunol; 2013 Aug; 173(2):195-206. PubMed ID: 23607751
[TBL] [Abstract][Full Text] [Related]
17. Circulating Exosomes Derived-miR-146a from Systemic Lupus Erythematosus Patients Regulates Senescence of Mesenchymal Stem Cells.
Dong C; Zhou Q; Fu T; Zhao R; Yang J; Kong X; Zhang Z; Sun C; Bao Y; Ge X; Zhang Z; Lu Z; Li J; Zheng W; Gu Z; Ji J
Biomed Res Int; 2019; 2019():6071308. PubMed ID: 31428639
[TBL] [Abstract][Full Text] [Related]
18. Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus.
Li X; Liu L; Meng D; Wang D; Zhang J; Shi D; Liu H; Xu H; Lu L; Sun L
Stem Cells Dev; 2012 Sep; 21(13):2387-94. PubMed ID: 22375903
[TBL] [Abstract][Full Text] [Related]
19. An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program.
Gnani D; Crippa S; Della Volpe L; Rossella V; Conti A; Lettera E; Rivis S; Ometti M; Fraschini G; Bernardo ME; Di Micco R
Aging Cell; 2019 Jun; 18(3):e12933. PubMed ID: 30828977
[TBL] [Abstract][Full Text] [Related]
20. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.
Cheng T; Ding S; Liu S; Li Y; Sun L
Theranostics; 2021; 11(2):893-905. PubMed ID: 33391511
[No Abstract] [Full Text] [Related]
[Next] [New Search]
